The trajectory of Viagra presents a interesting case for observers in the drug sector. While initially a tremendous success, creating billions, the exclusivity lapse and the subsequent entry of cheaper versions have significantly changed income. This poses questions about the long-term sustainability of similar medication innovations and suggests t